Back to search

Peptide record

TPDB42900

6E(V116-M135) Anticancer standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42900
6E(V116-M135)
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 30-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRRRRRRRGGVVELRVPTDLTLLPGHLYMM
Physicochemical Analysis
C157H275N59O38S2
ANCQIKFSW
R
3661.40
12.50
10
2
11
+7
8.72
-0.747
94.00
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
1490
40.69
3
Residue Composition
number
0
A
9
R
0
N
1
D
0
C
1
E
0
Q
3
G
1
H
0
I
5
L
0
K
2
M
0
F
2
P
0
S
2
T
0
W
1
Y
3
V
Amino Acid Distribution
A: 0 R: 9 N: 0 D: 1 C: 0 E: 1 Q: 0 G: 3 H: 1 I: 0 L: 5 K: 0 M: 2 F: 0 P: 2 S: 0 T: 2 W: 0 Y: 1 V: 3
Chemical Descriptors
30
C157H275N59O38S2
3661.40
12.50
+7
8.72
-0.747
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph figure 1-D
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.